Given the prolonged process of hematoma clearance, the persistent migration of detrimental CD8+ T cells from hematomas toward perihematomal tissues may hinder the resolution of brain inflammation, which may lead to chronic inflammation and impaired neurorepair after ICH. The gene discussed is CD8A; the disease is brain inflammatory disease.